NCT03906071 Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT03894891 Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer Status COMPLETED Phase PHASE2
NCT03891524 A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery Status COMPLETED Phase PHASE2
NCT03891108 A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03890809 An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage Status COMPLETED Phase PHASE1
NCT03890770 A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function and Participants With Mild to End-Stage Kidney Disease. Status COMPLETED Phase PHASE1
NCT03882008 A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis Status COMPLETED Phase PHASE4
NCT03881059 Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Status COMPLETED Phase PHASE2
NCT03879811 Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03879122 A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT03878979 Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN Status COMPLETED Phase PHASE2
NCT03873415 Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males Status COMPLETED Phase PHASE1
NCT03873402 A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03867916 Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients Status COMPLETED Phase NA
NCT03865082 Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03854032 Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03848052 Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Status RECRUITING Phase N/A
NCT03844256 A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study Status RECRUITING Phase PHASE1/PHASE2